Impact Biomedical Inc.
IBO- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001834105
In the last 90 days, Impact Biomedical Inc. insiders filed 0 open-market purchases and 1 sale; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.76M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Impact Biomedical Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 24 | 1 | 21 | −2 |
| Shares | 1.44M | 814.9K | 3.72M | +3.10M (+495.6%) |
| Value | $726.3K | $411.5K | $2.23M | +$1.92M (+609.7%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Impact Biomedical Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 708,168 | $424.9K | 0.00% |
| Vanguard Fiduciary Trust Co | 585,198 | $351.1K | 0.00% |
| Vanguard Global Advisers, LLC | 32,201 | $19.3K | 0.00% |
| Global Trust Asset Management, LLC | 1,818 | $1.09K | 0.00% |
| FMR LLC | 290 | $174 | 0.00% |
| Burk Holdings LLC | 27 | $16 | 0.00% |
| Center for Financial Planning, Inc. | 0 | $1 | 0.00% |
Sold out (9)
Institutions that held Impact Biomedical Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Millennium Management LLC | 137,823 | $69.6K |
| Two Sigma Securities, LLC | 22,695 | $11.5K |
| Susquehanna International Group, LLP | 16,501 | $8.33K |
| Jane Street Group, LLC | 14,086 | $7.11K |
| HRT Financial LP | 13,533 | $6.00K |
| Tower Research Capital LLC (TRC) | 1,426 | $720 |
| Bank of America Corp | 924 | $467 |
| Signature Resources Capital Management, LLC | 4 | $2 |
| Group One Trading, L.P. | 1 | $1 |
Not filed for Q1 2026 yet (1)
Institutions that held Impact Biomedical Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 814,885 | $411.5K |